First Oral Cellular Factor Drug For Tumor In Phase III Trials
This article was originally published in PharmAsia News
Executive Summary
Shanghai Institute of Biochemistry and Cell Biology under the Chinese Academy of Sciences, Zhejiang University, Zhejiang Sci-Tech University and the Key Laboratory of Bioreactor and Biopharmacy of Zhejiang province recently announced they have successfully developed an orally administered granulocyte-macrophage colony-stimulating factor, which is currently in Phase III clinical trials. GM-CSF injection has been used clinically but it is inconvenient and patients suffer from side effects. The latest research, published by open-accessed online journal PloS One, shows that Chinese scientists have discovered a breakthrough method of oral absorption for the cellular factor drug, a world first in tumor bio-treatment. (Click here for more - Chinese Language)